Clinical Trial Update: Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on dexmedetomidine and cognitive reserve with completed results related to perioperative cognitive function, delirium, and POCD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Postoperative Cognitive Dysfunction
• Postoperative Delirium

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Postoperative Delirium, PD | Phase 4 | Status: COMPLETED | Results posted: 2017-03-29